News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Japan Tobacco And GlaxoSmithKline (GSK) Conclude Licensing Agreement For New Drug Candidate


4/20/2006 11:04:07 AM

Tokyo, Apr 20, 2006 (JCN) - Japan Tobacco (JT) has signed a licensing agreement with GlaxoSmithKline (GSK) for a candidate compound developed by JT. Under the agreement, GSK will receive the worldwide exclusive right to develop and market the compound while JT retains co-promotion rights in Japan. In addition, JT will receive an upfront payment, milestone payments for development and royalties on future sales from GSK.


Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES